Esperion Therapeutics
ESPR
ESPR
141 hedge funds and large institutions have $1.38B invested in Esperion Therapeutics in 2015 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 45 increasing their positions, 26 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
7% more call options, than puts
Call options by funds: $46.4M | Put options by funds: $43.5M
Holders
141
Holding in Top 10
5
Calls
$46.4M
Puts
$43.5M
Top Buyers
| 1 | +$111M | |
| 2 | +$72.7M | |
| 3 | +$71.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$29.3M |
| 5 |
CCI
Columbus Circle Investors
|
+$22.3M |
Top Sellers
| 1 | -$26.7M | |
| 2 | -$22.9M | |
| 3 | -$16.1M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$14M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$8.77M |